Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149200222> ?p ?o ?g. }
- W2149200222 endingPage "781" @default.
- W2149200222 startingPage "769" @default.
- W2149200222 abstract "BackgroundUnderstanding the genetic basis of airflow obstruction and smoking behaviour is key to determining the pathophysiology of chronic obstructive pulmonary disease (COPD). We used UK Biobank data to study the genetic causes of smoking behaviour and lung health.MethodsWe sampled individuals of European ancestry from UK Biobank, from the middle and extremes of the forced expiratory volume in 1 s (FEV1) distribution among heavy smokers (mean 35 pack-years) and never smokers. We developed a custom array for UK Biobank to provide optimum genome-wide coverage of common and low-frequency variants, dense coverage of genomic regions already implicated in lung health and disease, and to assay rare coding variants relevant to the UK population. We investigated whether there were shared genetic causes between different phenotypes defined by extremes of FEV1. We also looked for novel variants associated with extremes of FEV1 and smoking behaviour and assessed regions of the genome that had already shown evidence for a role in lung health and disease. We set genome-wide significance at p<5 × 10−8.FindingsUK Biobank participants were recruited from March 15, 2006, to July 7, 2010. Sample selection for the UK BiLEVE study started on Nov 22, 2012, and was completed on Dec 20, 2012. We selected 50 008 unique samples: 10 002 individuals with low FEV1, 10 000 with average FEV1, and 5002 with high FEV1 from each of the heavy smoker and never smoker groups. We noted a substantial sharing of genetic causes of low FEV1 between heavy smokers and never smokers (p=2·29 × 10−16) and between individuals with and without doctor-diagnosed asthma (p=6·06 × 10−11). We discovered six novel genome-wide significant signals of association with extremes of FEV1, including signals at four novel loci (KANSL1, TSEN54, TET2, and RBM19/TBX5) and independent signals at two previously reported loci (NPNT and HLA-DQB1/HLA-DQA2). These variants also showed association with COPD, including in individuals with no history of smoking. The number of copies of a 150 kb region containing the 5′ end of KANSL1, a gene that is important for epigenetic gene regulation, was associated with extremes of FEV1. We also discovered five new genome-wide significant signals for smoking behaviour, including a variant in NCAM1 (chromosome 11) and a variant on chromosome 2 (between TEX41 and PABPC1P2) that has a trans effect on expression of NCAM1 in brain tissue.InterpretationBy sampling from the extremes of the lung function distribution in UK Biobank, we identified novel genetic causes of lung function and smoking behaviour. These results provide new insight into the specific mechanisms underlying airflow obstruction, COPD, and tobacco addiction, and show substantial shared genetic architecture underlying airflow obstruction across individuals, irrespective of smoking behaviour and other airway disease.FundingMedical Research Council. Understanding the genetic basis of airflow obstruction and smoking behaviour is key to determining the pathophysiology of chronic obstructive pulmonary disease (COPD). We used UK Biobank data to study the genetic causes of smoking behaviour and lung health. We sampled individuals of European ancestry from UK Biobank, from the middle and extremes of the forced expiratory volume in 1 s (FEV1) distribution among heavy smokers (mean 35 pack-years) and never smokers. We developed a custom array for UK Biobank to provide optimum genome-wide coverage of common and low-frequency variants, dense coverage of genomic regions already implicated in lung health and disease, and to assay rare coding variants relevant to the UK population. We investigated whether there were shared genetic causes between different phenotypes defined by extremes of FEV1. We also looked for novel variants associated with extremes of FEV1 and smoking behaviour and assessed regions of the genome that had already shown evidence for a role in lung health and disease. We set genome-wide significance at p<5 × 10−8. UK Biobank participants were recruited from March 15, 2006, to July 7, 2010. Sample selection for the UK BiLEVE study started on Nov 22, 2012, and was completed on Dec 20, 2012. We selected 50 008 unique samples: 10 002 individuals with low FEV1, 10 000 with average FEV1, and 5002 with high FEV1 from each of the heavy smoker and never smoker groups. We noted a substantial sharing of genetic causes of low FEV1 between heavy smokers and never smokers (p=2·29 × 10−16) and between individuals with and without doctor-diagnosed asthma (p=6·06 × 10−11). We discovered six novel genome-wide significant signals of association with extremes of FEV1, including signals at four novel loci (KANSL1, TSEN54, TET2, and RBM19/TBX5) and independent signals at two previously reported loci (NPNT and HLA-DQB1/HLA-DQA2). These variants also showed association with COPD, including in individuals with no history of smoking. The number of copies of a 150 kb region containing the 5′ end of KANSL1, a gene that is important for epigenetic gene regulation, was associated with extremes of FEV1. We also discovered five new genome-wide significant signals for smoking behaviour, including a variant in NCAM1 (chromosome 11) and a variant on chromosome 2 (between TEX41 and PABPC1P2) that has a trans effect on expression of NCAM1 in brain tissue. By sampling from the extremes of the lung function distribution in UK Biobank, we identified novel genetic causes of lung function and smoking behaviour. These results provide new insight into the specific mechanisms underlying airflow obstruction, COPD, and tobacco addiction, and show substantial shared genetic architecture underlying airflow obstruction across individuals, irrespective of smoking behaviour and other airway disease." @default.
- W2149200222 created "2016-06-24" @default.
- W2149200222 creator A5001938237 @default.
- W2149200222 creator A5005885222 @default.
- W2149200222 creator A5008567943 @default.
- W2149200222 creator A5011255987 @default.
- W2149200222 creator A5012115483 @default.
- W2149200222 creator A5013273481 @default.
- W2149200222 creator A5021519599 @default.
- W2149200222 creator A5023211986 @default.
- W2149200222 creator A5023864226 @default.
- W2149200222 creator A5025775908 @default.
- W2149200222 creator A5030603878 @default.
- W2149200222 creator A5030725617 @default.
- W2149200222 creator A5031473751 @default.
- W2149200222 creator A5031990107 @default.
- W2149200222 creator A5036032984 @default.
- W2149200222 creator A5043513022 @default.
- W2149200222 creator A5044451947 @default.
- W2149200222 creator A5045227106 @default.
- W2149200222 creator A5047195306 @default.
- W2149200222 creator A5049025189 @default.
- W2149200222 creator A5049688135 @default.
- W2149200222 creator A5051043751 @default.
- W2149200222 creator A5054008224 @default.
- W2149200222 creator A5056218976 @default.
- W2149200222 creator A5062174800 @default.
- W2149200222 creator A5062324476 @default.
- W2149200222 creator A5063172840 @default.
- W2149200222 creator A5066779629 @default.
- W2149200222 creator A5068163296 @default.
- W2149200222 creator A5073972430 @default.
- W2149200222 creator A5074791258 @default.
- W2149200222 creator A5076319691 @default.
- W2149200222 creator A5077109568 @default.
- W2149200222 creator A5081927817 @default.
- W2149200222 creator A5082712082 @default.
- W2149200222 creator A5085940785 @default.
- W2149200222 creator A5088705612 @default.
- W2149200222 creator A5090081649 @default.
- W2149200222 creator A5090890914 @default.
- W2149200222 date "2015-10-01" @default.
- W2149200222 modified "2023-10-13" @default.
- W2149200222 title "Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank" @default.
- W2149200222 cites W1907868928 @default.
- W2149200222 cites W1966496414 @default.
- W2149200222 cites W1971000546 @default.
- W2149200222 cites W1978124765 @default.
- W2149200222 cites W1980726773 @default.
- W2149200222 cites W1990396035 @default.
- W2149200222 cites W2003818007 @default.
- W2149200222 cites W2005623173 @default.
- W2149200222 cites W2006720016 @default.
- W2149200222 cites W2007669329 @default.
- W2149200222 cites W2008175710 @default.
- W2149200222 cites W2021085462 @default.
- W2149200222 cites W2026114862 @default.
- W2149200222 cites W2029561500 @default.
- W2149200222 cites W2037645843 @default.
- W2149200222 cites W2040421689 @default.
- W2149200222 cites W2047419400 @default.
- W2149200222 cites W2055245602 @default.
- W2149200222 cites W2058601962 @default.
- W2149200222 cites W2058608805 @default.
- W2149200222 cites W2074014788 @default.
- W2149200222 cites W2082704080 @default.
- W2149200222 cites W2084988623 @default.
- W2149200222 cites W2094379190 @default.
- W2149200222 cites W2096118746 @default.
- W2149200222 cites W2098597355 @default.
- W2149200222 cites W2099598799 @default.
- W2149200222 cites W2103465143 @default.
- W2149200222 cites W2104443125 @default.
- W2149200222 cites W2104704131 @default.
- W2149200222 cites W2106724486 @default.
- W2149200222 cites W2107766358 @default.
- W2149200222 cites W2110846909 @default.
- W2149200222 cites W2111344085 @default.
- W2149200222 cites W2113778517 @default.
- W2149200222 cites W2118552444 @default.
- W2149200222 cites W2122791877 @default.
- W2149200222 cites W2125065061 @default.
- W2149200222 cites W2125078269 @default.
- W2149200222 cites W2127175782 @default.
- W2149200222 cites W2133191097 @default.
- W2149200222 cites W2133517490 @default.
- W2149200222 cites W2135199713 @default.
- W2149200222 cites W2148351250 @default.
- W2149200222 cites W2152885121 @default.
- W2149200222 cites W2161998322 @default.
- W2149200222 cites W2165277651 @default.
- W2149200222 cites W2168850818 @default.
- W2149200222 cites W2171777347 @default.
- W2149200222 cites W2189024098 @default.
- W2149200222 cites W2216458865 @default.
- W2149200222 cites W2334369600 @default.
- W2149200222 doi "https://doi.org/10.1016/s2213-2600(15)00283-0" @default.
- W2149200222 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4593935" @default.